$CAMT
CAMTEK LTD Stock $camt

$camt Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 20-F Financial Statement

#000117891324001028 Filed on March 21, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$97.01M	$88.69M	$315.4M
YoY Change	33.89%	7.93%	-1.72%
Cost Of Revenue	$52.29M	$48.90M	$167.7M
YoY Change	35.48%	15.8%	4.15%
Gross Profit	$44.72M	$39.79M	$147.6M
YoY Change	32.07%	-0.4%	-7.65%
Gross Profit Margin	46.1%	44.86%	46.81%
Selling, General & Admin	$14.57M	$14.53M	$50.75M
YoY Change	20.29%	13.48%	2.53%
% of Gross Profit	32.59%	36.51%	34.38%
Research & Development	$8.912M	$8.042M	$31.47M
YoY Change	17.98%	20.32%	9.05%
% of Gross Profit	19.93%	20.21%	21.32%
Depreciation & Amortization			$5.784M
YoY Change			41.28%
% of Gross Profit			3.92%
Operating Expenses	$23.49M	$22.57M	$82.22M
YoY Change	19.4%	15.83%	4.93%
Operating Profit	$21.24M	$17.22M	$65.41M
YoY Change	49.62%	-15.84%	-19.74%
Interest Expense	$5.610M	$5.682M	$22.22M
YoY Change	9.78%	49.49%	232.11%
% of Operating Profit	26.41%	33.0%	33.97%
Other Income/Expense, Net			-$739.0K
YoY Change			-14.47%
Pretax Income	$26.85M	$22.90M	$87.63M
YoY Change	39.07%	-5.61%	-0.63%
Income Tax	$2.049M	$2.111M	$8.998M
% Of Pretax Income	7.63%	9.22%	10.27%
Net Earnings	$24.80M	$20.79M	$78.63M
YoY Change	43.8%	-4.07%	-1.65%
Net Earnings / Revenue	25.56%	23.44%	24.93%
Basic Earnings Per Share			$1.76
Diluted Earnings Per Share	$0.50	$0.42	$1.61
COMMON SHARES
Basic Shares Outstanding	44.90M		44.73K
Diluted Shares Outstanding			48.86K

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$377.2M	$354.0M	$354.0M
YoY Change	-9.26%	-11.42%	-11.42%
Cash & Equivalents	$123.0M	$120.0M	$120.0M
Short-Term Investments	$254.2M	$234.1M	$234.1M
Other Short-Term Assets	$23.26M	$19.55M	$19.55M
YoY Change	54.72%	75.22%	75.22%
Inventory	$92.08M	$85.91M	$85.91M
Prepaid Expenses		$5.164M
Receivables	$86.37M	$87.30M	$87.30M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$578.9M	$546.8M	$546.8M
YoY Change	3.09%	-1.83%	-1.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$42.77M	$41.99M	$41.99M
YoY Change	21.45%	26.69%	26.69%
Goodwill		$74.35M
YoY Change
Intangibles		$16.94M
YoY Change		2737.02%
Long-Term Investments	$83.78M	$73.58M	$73.58M
YoY Change
Other Assets	$20.46M	$34.04M	$34.04M
YoY Change	-76.21%	-60.6%	-60.6%
Total Long-Term Assets	$237.4M	$240.9M	$240.9M
YoY Change	94.9%	100.53%	100.53%
TOTAL ASSETS
Total Short-Term Assets	$578.9M	$546.8M	$546.8M
Total Long-Term Assets	$237.4M	$240.9M	$240.9M
Total Assets	$816.3M	$787.7M	$787.7M
YoY Change	19.45%	16.33%	16.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$38.87M	$42.19M	$42.19M
YoY Change	38.53%	33.22%	33.22%
Accrued Expenses		$20.88M	$20.88M
YoY Change			16.21%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$158.1M	$96.67M	$96.67M
YoY Change	112.41%	9.24%	9.24%
LONG-TERM LIABILITIES
Long-Term Debt	$197.1M	$196.8M	$196.8M
YoY Change	0.56%	0.56%	0.56%
Other Long-Term Liabilities	$11.11M	$10.47M	$10.47M
YoY Change	32.92%	19.72%	19.72%
Total Long-Term Liabilities	$208.2M	$207.3M	$207.3M
YoY Change	1.88%	1.38%	1.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$158.1M	$96.67M	$96.67M
Total Long-Term Liabilities	$208.2M	$207.3M	$207.3M
Total Liabilities	$372.7M	$311.5M	$311.5M
YoY Change	33.68%	6.33%	6.33%
SHAREHOLDERS EQUITY
Retained Earnings		$277.4M
YoY Change		39.57%
Common Stock		$200.6M
YoY Change		7.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$1.898M
YoY Change		0.0%
Treasury Stock Shares
Shareholders Equity	$443.6M	$476.1M	$476.1M
YoY Change
Total Liabilities & Shareholders Equity	$816.3M	$787.7M	$787.7M
YoY Change	19.45%	16.33%	16.33%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$24.80M	$20.79M	$78.63M
YoY Change	43.8%	-4.07%	-1.65%
Depreciation, Depletion And Amortization			$5.784M
YoY Change			41.28%
Cash From Operating Activities			$79.32M
YoY Change			37.24%
INVESTING ACTIVITIES
Capital Expenditures			$8.097M
YoY Change			-1.22%
Acquisitions
YoY Change
Other Investing Activities			-$99.18M
YoY Change			-30.4%
Cash From Investing Activities			-$107.5M
YoY Change			-28.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			$182.0K
YoY Change			5966.67%
NET CHANGE
Cash From Operating Activities			$79.32M
Cash From Investing Activities			-$107.5M
Cash From Financing Activities			$182.0K
Net Change In Cash			-$28.19M
YoY Change			-69.94%
FREE CASH FLOW
Cash From Operating Activities			$79.32M
Capital Expenditures			$8.097M
Free Cash Flow			$71.23M
YoY Change			43.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-30664
CY2023	dei	Entity Registrant Name EntityRegistrantName	Camtek Ltd.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	23150
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	P.O. BOX 544
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Migdal Ha’Emek
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44901622
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119968000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	148156000	usd
CY2023Q4	us-gaap	Restricted Investments Current RestrictedInvestmentsCurrent	215250000	usd
CY2022Q4	us-gaap	Restricted Investments Current RestrictedInvestmentsCurrent	251500000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	87300000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	80611000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	85905000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	65541000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	19548000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	11156000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	546787000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	556964000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	21000000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	79000000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9023000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	5357000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2642000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1004000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1370000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41987000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33141000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16937000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	597000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	240880000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	120123000	usd
CY2022Q4	us-gaap	Assets Assets	677087000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	42187000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	31667000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	195737000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	214845000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	204485000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	311519000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	292985000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46993998
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46505318
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44901622
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44412942
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	176000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	175000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	200389000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	187105000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	277352000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	198720000	usd
CY2023Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	478046000	usd
CY2022Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	386000000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1898000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1898000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	476148000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	384102000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	787667000	usd
CY2021	us-gaap	Revenues Revenues	269659000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	167742000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	132315000	usd
CY2023	us-gaap	Gross Profit GrossProfit	147633000	usd
CY2022	us-gaap	Gross Profit GrossProfit	159856000	usd
CY2021	us-gaap	Gross Profit GrossProfit	137344000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31470000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28859000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23473000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	50751000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49499000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42973000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	82221000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	78358000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	66446000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	65412000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	81498000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	70898000	usd
CY2023	camt	Financial Income Expenses Net FinancialIncomeExpensesNet	22218000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	71928000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8998000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8239000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11651000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	78632000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	79949000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	60277000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.76
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.81
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.38
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.63
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.68
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.34
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44725
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44158
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43644
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48863
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48229
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45035
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	227264000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	293627000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	3000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	79949000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	384102000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	182000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	78632000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	78632000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	79949000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	60277000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5784000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4094000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2811000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1254000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-777000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	255000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1094000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1094000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	113000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12598000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10523000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5815000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	100000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-7000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-32000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-6000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-4000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1890000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	21984000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17338000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9518000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21702000	usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	3000	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	0	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	12000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	6766000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	6337000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2875000	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	26956000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	79324000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	57799000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	60957000	usd
CY2023	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-36250000	usd
CY2022	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	95500000	usd
CY2021	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	84000000	usd
CY2023	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-58000000	usd
CY2022	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	47000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-107453000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-150794000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-120176000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	182000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	271000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	194530000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	182000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	194801000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-241000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	546000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-28188000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-93787000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	136128000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148156000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	241943000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105815000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119968000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148156000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	241943000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	13807000	usd
CY2023	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1854000	usd
CY2022	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1480000	usd
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1060000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	6867000	usd
CY2023	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	8934000	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	4508000	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	4248000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	13993000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	9567000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	9567000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119968000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	148156000	usd
CY2023Q4	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	55598000	usd
CY2022Q4	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	43017000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	20038000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	13951000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19292000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13930000	usd
CY2023Q4	camt	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	94928000	usd
CY2022Q4	camt	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	70898000	usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	8386000	usd
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	3979000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5164000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3832000	usd
CY2023Q4	camt	Other Assets Due From Government Institutions OtherAssetsDueFromGovernmentInstitutions	3690000	usd
CY2022Q4	camt	Other Assets Due From Government Institutions OtherAssetsDueFromGovernmentInstitutions	2598000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	2308000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	747000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	19548000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	11156000	usd
CY2023	camt	Percentage Of Average Annual Interest Rates PercentageOfAverageAnnualInterestRates	0.0559
CY2022	camt	Percentage Of Average Annual Interest Rates PercentageOfAverageAnnualInterestRates	0.0445
CY2023Q4	camt	Deferred Revenue Expected To Be Recognized In Next Fiscal Year DeferredRevenueExpectedToBeRecognizedInNextFiscalYear	6262000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25085000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20900000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41987000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33141000	usd
CY2023	us-gaap	Depreciation Depreciation	6428000	usd
CY2022	us-gaap	Depreciation Depreciation	5252000	usd
CY2021	us-gaap	Depreciation Depreciation	3682000	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	2308000	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	2135000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2271000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1538000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16937000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	597000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	733000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	110000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	110000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3827000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3652000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2805000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2795000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2378000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1094000	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	258941000	usd
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	152565000	usd
CY2023Q4	camt	Debt Instrument Additional Face Amount DebtInstrumentAdditionalFaceAmount	58941000	usd
CY2022Q4	camt	Debt Instrument Additional Face Amount DebtInstrumentAdditionalFaceAmount	47435000	usd
CY2022Q4	camt	Right Of Use Assets Opening Balance Gross RightOfUseAssetsOpeningBalanceGross	6087000	usd
CY2021Q4	camt	Right Of Use Assets Opening Balance Gross RightOfUseAssetsOpeningBalanceGross	4969000	usd
CY2023	camt	Right Of Use Assets Additions RightOfUseAssetsAdditions	2573000	usd
CY2022	camt	Right Of Use Assets Additions RightOfUseAssetsAdditions	2079000	usd
CY2023	camt	Right Of Use Assets Disposals RightOfUseAssetsDisposals	1473000	usd
CY2022	camt	Right Of Use Assets Disposals RightOfUseAssetsDisposals	961000	usd
CY2023Q4	camt	Right Of Use Assets Opening Balance Gross RightOfUseAssetsOpeningBalanceGross	7187000	usd
CY2022Q4	camt	Right Of Use Assets Opening Balance Gross RightOfUseAssetsOpeningBalanceGross	6087000	usd
CY2023Q4	camt	Right Of Use Assets Accumulated Depreciation RightOfUseAssetsAccumulatedDepreciation	2866000	usd
CY2022Q4	camt	Right Of Use Assets Accumulated Depreciation RightOfUseAssetsAccumulatedDepreciation	2386000	usd
CY2023Q4	camt	Operating Lease Right Of Use Asset For Gross Lease Costs OperatingLeaseRightOfUseAssetForGrossLeaseCosts	1854000	usd
CY2022Q4	camt	Operating Lease Right Of Use Asset For Gross Lease Costs OperatingLeaseRightOfUseAssetForGrossLeaseCosts	1480000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1947000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1733000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	911000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4803000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	482000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P32M
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	51110000	usd
CY2022Q4	us-gaap	Purchase Obligation PurchaseObligation	43169000	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	39000	usd
CY2021	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	32000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7000	usd
CY2022	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	7000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	100000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	100000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.035
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P1Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1207000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	375000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	738000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	21318
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.96
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22102
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.66
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.8
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16224
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	31.5
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5704
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	36.45
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	106
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.38
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	11445
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	16.41
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	784
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.38
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	73421
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.67
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.99
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	21318
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.96
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22102
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.66
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	22577
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	16.78
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16224
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.32
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	12704
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	7.87
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	0
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	3520
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	28.4
CY2023	us-gaap	Net Income Loss NetIncomeLoss	78632000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	79949000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	60277000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44725
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44158
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43644
CY2023	us-gaap	Net Income Loss NetIncomeLoss	78632000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	79949000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	60277000	usd
CY2023	camt	Amortization Of Notes Issuance Costs AmortizationOfNotesIssuanceCosts	1094000	usd
CY2022	camt	Amortization Of Notes Issuance Costs AmortizationOfNotesIssuanceCosts	1094000	usd
CY2021	camt	Amortization Of Notes Issuance Costs AmortizationOfNotesIssuanceCosts	105000	usd
CY2023	camt	Net Income Loss Used In Diluted Earnings Per Share Calculation NetIncomeLossUsedInDilutedEarningsPerShareCalculation	79726000	usd
CY2022	camt	Net Income Loss Used In Diluted Earnings Per Share Calculation NetIncomeLossUsedInDilutedEarningsPerShareCalculation	81043000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44158
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43644
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	717
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	650
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	988
CY2023	camt	Effect Of Conversion Of Notes EffectOfConversionOfNotes	3421000	usd
CY2022	camt	Effect Of Conversion Of Notes EffectOfConversionOfNotes	3421000	usd
CY2021	camt	Effect Of Conversion Of Notes EffectOfConversionOfNotes	403000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48863
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.34
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3520
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5704
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2023	us-gaap	Revenues Revenues	315375000	usd
CY2022	us-gaap	Revenues Revenues	320909000	usd
CY2021	us-gaap	Revenues Revenues	269659000	usd
CY2022	us-gaap	Revenues Revenues	320909000	usd
CY2021	us-gaap	Revenues Revenues	269659000	usd
CY2023	us-gaap	Selling Expense SellingExpense	36896000	usd
CY2022	us-gaap	Selling Expense SellingExpense	38249000	usd
CY2021	us-gaap	Selling Expense SellingExpense	33614000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13855000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11250000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9359000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49499000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42973000	usd
CY2023	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	2744000	usd
CY2023	camt	Convertible Notes Amortization ConvertibleNotesAmortization	-1094000	usd
CY2022	camt	Convertible Notes Amortization ConvertibleNotesAmortization	-1094000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-265000	usd
CY2023	camt	Financial Income Expenses Net FinancialIncomeExpensesNet	22218000	usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.23
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.23
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.23
CY2021	camt	Corporate Statutory Tax Rate On2018 And Thereafter CorporateStatutoryTaxRateOn2018AndThereafter	0.075
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	84186000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	82933000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	67643000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3444000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5255000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	4285000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	87630000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	88188000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	71928000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	8054000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	6973000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2198000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2043000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1603000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	10252000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	9016000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11533000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	109000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	714000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1363000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-775000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-596000	usd
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-1254000	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-777000	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	118000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	20154000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	20283000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	16543000	usd
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	usd
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	5306000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	651000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	358000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	285000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	2186000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1598000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve	647000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve	638000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	35000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	442000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	344000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	762000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	589000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4037000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	938000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	795000	usd
CY2023Q4	camt	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	442000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001109138
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Ramat Gavriel Industrial Zone
CY2023	dei	Entity Address Country EntityAddressCountry	IL
CY2023	dei	Security12b Title Security12bTitle	Ordinary Shares, nominal value NIS 0.01 per share
CY2023	dei	Trading Symbol TradingSymbol	CAMT
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	1057
CY2023	dei	Auditor Name AuditorName	Somekh Chaikin
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	18816000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	73576000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1024000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	74345000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2023Q4	us-gaap	Assets Assets	787667000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54487000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	56833000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	96674000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	88500000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7541000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10473000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8748000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	196831000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	129000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2092376
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2092376
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	677087000	usd
CY2023	us-gaap	Revenues Revenues	315375000	usd
CY2022	us-gaap	Revenues Revenues	320909000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	161053000	usd
CY2022	camt	Financial Income Expenses Net FinancialIncomeExpensesNet	6690000	usd
CY2021	camt	Financial Income Expenses Net FinancialIncomeExpensesNet	1030000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	87630000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	88188000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	78632000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	79949000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	60277000	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	740000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2023	camt	Other Comprehensive Income Loss Deferred Tax Changes Net Of Tax OtherComprehensiveIncomeLossDeferredTaxChangesNetOfTax	611000	usd
CY2022	camt	Other Comprehensive Income Loss Deferred Tax Changes Net Of Tax OtherComprehensiveIncomeLossDeferredTaxChangesNetOfTax	0	usd
CY2021	camt	Other Comprehensive Income Loss Deferred Tax Changes Net Of Tax OtherComprehensiveIncomeLossDeferredTaxChangesNetOfTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	129000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	78761000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	79949000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	60277000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	271000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5815000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	60277000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10523000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12598000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	505000	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	740000	usd
CY2023	camt	Other Comprehensive Income Loss Deferred Tax Changes Net Of Tax OtherComprehensiveIncomeLossDeferredTaxChangesNetOfTax	611000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	476148000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13692000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2380000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	10121000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2113000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	6190000	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-5406000	usd
CY2023	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	101781000	usd
CY2022	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	0	usd
CY2021	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	0	usd
CY2021	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	32000000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8097000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8197000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4065000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	173000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	97000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	111000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	103528000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	11876000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-795000	usd
CY2023Q4	camt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Working Capital Excluding Cash And Cash Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalExcludingCashAndCashEquivalents	-15288000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets	1615000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	16900000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	74345000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	7157000	usd
CY2023Q4	camt	Business Combination Recognized Working Capital Adjustments BusinessCombinationRecognizedWorkingCapitalAdjustments	1295000	usd
CY2023Q4	camt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capitalized Share Based Compensation Adjustment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalizedShareBasedCompensationAdjustment	102286000	usd
CY2023Q4	camt	Business Combination Recognized Increase In Goodwill Against Share Based Compensation BusinessCombinationRecognizedIncreaseInGoodwillAgainstShareBasedCompensation	505000	usd
CY2023	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	101781000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	11836000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	558000	usd
CY2023	camt	Interest Received InterestReceived	18685000	usd
CY2022	camt	Interest Received InterestReceived	4293000	usd
CY2021	camt	Interest Received InterestReceived	1057000	usd
CY2023	camt	Fixed Assets Purchased With Supplier Credit FixedAssetsPurchasedWithSupplierCredit	267000	usd
CY2022	camt	Fixed Assets Purchased With Supplier Credit FixedAssetsPurchasedWithSupplierCredit	569000	usd
CY2021	camt	Fixed Assets Purchased With Supplier Credit FixedAssetsPurchasedWithSupplierCredit	339000	usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	200000000	usd
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0
CY2021Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	25000000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	194530000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:35.4pt"> </td> <td style="width:35.5pt;vertical-align:top;align:right;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>C.</span></span></span></span></span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Use of estimates</span></span></span></span></span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:35.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. As applicable to these financial statements, the most significant estimates and assumptions relate to revenue recognition, valuation of accounts receivable, acquired intangible assets and inventories. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.</span></span></span></span></span></span></div> </div>
CY2023	camt	Average Annual Interest Rate For Short Term Deposits AverageAnnualInterestRateForShortTermDeposits	0.0581
CY2022	camt	Average Annual Interest Rate For Short Term Deposits AverageAnnualInterestRateForShortTermDeposits	0.0422
CY2022	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	6948000	usd
CY2023	camt	Lease Borrowing Rate LeaseBorrowingRate	0.07
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	91652000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	752000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	12000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	92392000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	18804000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	18816000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	72210000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	72908000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	638000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	668000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	91652000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	92392000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2786000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	9000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	2368000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3000	usd
CY2023Q4	us-gaap	Other Inventory Inventory At Off Site Premises OtherInventoryInventoryAtOffSitePremises	8626000	usd
CY2022Q4	us-gaap	Other Inventory Inventory At Off Site Premises OtherInventoryInventoryAtOffSitePremises	5664000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	85905000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	65541000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9023000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	5357000	usd
CY2023Q4	camt	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	94928000	usd
CY2022Q4	camt	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	70898000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9023000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	5357000	usd
CY2023	camt	Period Of Customer Support PeriodOfCustomerSupport	seven to ten years
CY2023Q4	camt	Provision For Damages Obsolete Excess And Slow Moving Inventory ProvisionForDamagesObsoleteExcessAndSlowMovingInventory	1204000	usd
CY2022Q4	camt	Provision For Damages Obsolete Excess And Slow Moving Inventory ProvisionForDamagesObsoleteExcessAndSlowMovingInventory	263000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	67072000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	54041000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	12200000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	0	usd
CY2023Q4	us-gaap	Finite Lived Trade Names Gross FiniteLivedTradeNamesGross	2700000	usd
CY2022Q4	us-gaap	Finite Lived Trade Names Gross FiniteLivedTradeNamesGross	0	usd
CY2023Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	2000000	usd
CY2022Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19208000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2135000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3161000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3265000	usd
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2328000	usd
CY2023	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5505000	usd
CY2022	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5823000	usd
CY2021	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	6333000	usd
CY2023	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	5269000	usd
CY2022	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	5927000	usd
CY2021	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	5396000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3397000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3161000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3265000	usd
CY2023Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	1577000	usd
CY2022Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	1284000	usd
CY2023Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	6262000	usd
CY2022Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	5060000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2634000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2404000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10473000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8748000	usd
CY2023Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	1577000	usd
CY2022Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	1284000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	1936000	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	1903000	usd
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	1636000	usd
CY2023	camt	Term Of Debt Issuance Costs Amortization TermOfDebtIssuanceCostsAmortization	P3Y
CY2023	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0056
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1094000	usd
CY2023Q4	camt	Right Of Use Asset Operating Lease RightOfUseAssetOperatingLease	4321000	usd
CY2022Q4	camt	Right Of Use Asset Operating Lease RightOfUseAssetOperatingLease	3701000	usd
CY2023Q4	camt	Operating Lease Liability Net Of Lease Incentive Obligation Current OperatingLeaseLiabilityNetOfLeaseIncentiveObligationCurrent	1687000	usd
CY2022Q4	camt	Operating Lease Liability Net Of Lease Incentive Obligation Current OperatingLeaseLiabilityNetOfLeaseIncentiveObligationCurrent	1297000	usd
CY2023Q4	camt	Operating Lease Liability Net Of Lease Incentive Obligation Non Current OperatingLeaseLiabilityNetOfLeaseIncentiveObligationNonCurrent	2634000	usd
CY2022Q4	camt	Operating Lease Liability Net Of Lease Incentive Obligation Non Current OperatingLeaseLiabilityNetOfLeaseIncentiveObligationNonCurrent	2404000	usd
CY2023Q4	camt	Operating Lease Liability Net Of Lease Incentive Obligation OperatingLeaseLiabilityNetOfLeaseIncentiveObligation	4321000	usd
CY2022Q4	camt	Operating Lease Liability Net Of Lease Incentive Obligation OperatingLeaseLiabilityNetOfLeaseIncentiveObligation	3701000	usd
CY2021Q4	camt	Operating Lease Right Of Use Asset For Gross Lease Costs OperatingLeaseRightOfUseAssetForGrossLeaseCosts	1060000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	212000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16224
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.39
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.48
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.02
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.04
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1189000	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	375000	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	683000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	3520
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	89925
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	26097
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	21318
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.96
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	16398
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.38
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	22577
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	16.67
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M23D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1189000	usd
CY2021	camt	Net Income Loss Used In Diluted Earnings Per Share Calculation NetIncomeLossUsedInDilutedEarningsPerShareCalculation	60382000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44725
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48229
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45035
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.76
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.81
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.38
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.63
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.68
CY2023Q4	camt	Long Lived Assets Percentage LongLivedAssetsPercentage	1
CY2022Q4	camt	Long Lived Assets Percentage LongLivedAssetsPercentage	1
CY2023	us-gaap	Revenues Revenues	315375000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	50751000	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	2294000	usd
CY2021	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	1867000	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	24051000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	8648000	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	1408000	usd
CY2021	camt	Convertible Notes Amortization ConvertibleNotesAmortization	-113000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-739000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-864000	usd
CY2022	camt	Financial Income Expenses Net FinancialIncomeExpensesNet	6690000	usd
CY2021	camt	Financial Income Expenses Net FinancialIncomeExpensesNet	1030000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-78000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-351000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	58000	usd
CY2021	camt	One Time Tax Expense OneTimeTaxExpense	5315000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	9930000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8998000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8239000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11651000	usd
CY2023	camt	Tax Expense On Gains And Losses On Intra Entity Foreign Currency Transactions TaxExpenseOnGainsAndLossesOnIntraEntityForeignCurrencyTransactions	611000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	87630000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	88188000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	71928000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-12417000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-12702000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-10715000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	610000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	300000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	232000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8998000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8239000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11651000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3204000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	1430000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4885000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	usd
CY2022Q4	camt	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	344000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	1241000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	1061000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	8936000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-4899000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1004000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2642000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1004000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7541000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-4899000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1004000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	1718000	usd

Files In Submission

Name	View Source	Status
0001178913-24-001028-index-headers.html	Edgar Link	pending
0001178913-24-001028-index.html	Edgar Link	pending
0001178913-24-001028.txt	Edgar Link	pending
0001178913-24-001028-xbrl.zip	Edgar Link	pending
camt-20231231.xsd	Edgar Link	pending
exhibit_12-1.htm	Edgar Link	pending
exhibit_12-2.htm	Edgar Link	pending
exhibit_13-1.htm	Edgar Link	pending
exhibit_15-1.htm	Edgar Link	pending
exhibit_2-1.htm	Edgar Link	pending
exhibit_4-5.htm	Edgar Link	pending
exhibit_8-1.htm	Edgar Link	pending
exhibit_97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
camt-20231231_def.xml	Edgar Link	unprocessable
camt-20231231_lab.xml	Edgar Link	unprocessable
camt-20231231_pre.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk2431123.htm	Edgar Link	pending
zk2431123_htm.xml	Edgar Link	completed
camt-20231231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CAMT
CAMTEK LTD Stock $camt

2024 Q1 Form 20-F Financial Statement

#000117891324001028 Filed on March 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAMT CAMTEK LTD Stock $camt

2024 Q1 Form 20-F Financial Statement

#000117891324001028 Filed on March 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAMT
CAMTEK LTD Stock $camt